Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

76.19 +0.19 (+0.25%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,899,215
Open 76.20
Bid (Size) 75.25 (1)
Ask (Size) 77.00 (2)
Prev. Close 76.00
Today's Range 75.74 - 76.73
52wk Range 58.93 - 95.73
Shares Outstanding 589,800,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top S&P500 movers in Wednesday's session
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength
Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company projects continued expansion in 2025. 
Via Benzinga

Performance

YTD
+4.96%
+4.96%
1 Month
+9.06%
+9.06%
3 Month
+9.01%
+9.01%
6 Month
+11.62%
+11.62%
1 Year
-11.51%
-11.51%

More News

Read More
These S&P500 stocks are moving in today's session
Via Chartmill
Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy
Exposures Interest Rates
11 Analysts Have This To Say About Edwards Lifesciences
Via Benzinga
Discover the top S&P500 movers in Wednesday's pre-market session.
Via Chartmill
Edwards Beats Fourth-Quarter Forecasts, But Shares Slip
Via Investor's Business Daily
Edwards Lifesciences Reports Fourth Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences (EW) Reports Q4: Everything You Need To Know Ahead Of Earnings
Via StockStory
Assessing Edwards Lifesciences: Insights From 20 Financial Analysts
Via Benzinga
US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday?
Via Benzinga
EDWARDS LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW
From Kahn Swick & Foti, LLC
Via Business Wire
Earnings Scheduled For February 11, 2025
Via Benzinga
Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion
Via Benzinga
This Coca-Cola Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
EDWARDS LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Edwards Lifesciences Corporation - EW
From Kahn Swick & Foti, LLC
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Jan. 18
Via Talk Markets
Topics Stocks / Equities
Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
Good technical signals and a possible breakout for EDWARDS LIFESCIENCES CORP.
Via Chartmill
EDWARDS ALERT: Bragar Eagel & Squire, P.C. is Investigating Edwards Lifesciences Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Technical Signals Point to a Possible Breakout for EDWARDS LIFESCIENCES CORP.
Via Chartmill
Levi & Korsinsky Reminds Edwards Lifesciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 13, 2024 – EW
Via ACCESSWIRE
Edwards Lifesciences Corporation Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EW
Via ACCESSWIRE
Investors who lost money on Edwards Lifesciences Corporation (EW) should contact Levi & Korsinsky about pending Class Action - EW
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.